Eli Lilly and Company (LLY.DE) XETRA

918.50

-13.8(-1.48%)

Updated at January 14 05:35PM

Currency In EUR

Valuation

Market Cap693.46B
Enterprise Value723.83B
P/E Ratio52.47
PEG Ratio1.57
Price/Sales Ratio16.28
Price/Book Ratio40.61
Enterprise/Revenue16.84
Enterprise/EBITDA39.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.31
Operating Margin0.44

Management Effectiveness

Return On Assets0.16
Return On Equity1.02

Income Statement

Revenue45.04B
Revenue/Share66.25
Gross Profit36.62B
EBITDA15.23B
Net Income10.59B
Diluted EPS11.71

Balance Sheet

Total Cash9.91B
Total Cash/Share11.05
Total Debt42.51B
Total Debt/Equity1.79
Current Ratio1.55
Book Value Per Share26.59

Price History

52-Week Change28.19
52-Week High971.1
52-Week Low535.8
Moving Average 50 Days893.25
Moving Average 200 Days724.11

Statistics

Average Volume2,677
Shares Outstanding898.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate6
Trailing Annual Dividend Yield0.56
Payout Ratio0.28
Last Split FactorN/A
Last Split DateN/A